Приоритетные аспекты изучения проблемы ТБ/ВИЧ в условиях ...

Приоритетные аспекты изучения проблемы ТБ/ВИЧ в условиях высокой распространенности ВИЧ-инфекции и ограниченных ресурсов22 WHO. WHO policy on TB infection controlin health-care facilities, congregate settingsand households. Geneva, World HealthOrganization, 2009. http://whqlibdoc.who.int/publications/2009/9789241598323_eng.pdf23 Moro ML, Errante I, Infuso A et al. Effectivenessof infection control measures in controlling anosocomial outbreak of multidrug-resistanttuberculosis among HIV patients in Italy. Int J TubercLung Dis, 2000, 4(1):61-68.24 Harries AD, Hargreaves NJ, Gausi F et al. Preventingtuberculosis among health workers in Malawi. BullWorld Health Organ, 2002, 80(7):526-531.25 Yanai H, Limpakarnjanarat K, Uthaivoravit W et al.Risk of Mycobacterium tuberculosis infection anddisease among health care workers, Chiang Rai,Thailand. Int J Tuberc Lung Dis, 2003, 7(1):36-45.26 Escombe AR, Oeser CC, Gilman RH et al. Naturalventilation for the prevention of airbornecontagion. PLoS Med, 2007, 4(2):e68.27 Escombe AR, Moore DA, Gilman RH et al. Upperroomultraviolet light and negative air ionization toprevent tuberculosis transmission. PLoS Med, 2009,6(3):e43.28 Basu S, Andrews JR, Poolman EM et al. Preventionof nosocomial transmission of extensively drugresistanttuberculosis in rural South African districthospitals: an epidemiological modelling study.Lancet, 2007, 370(9597):1500-1507.29 Lawn SD, Kranzer K, Wood R. Antiretroviral therapyfor control of the HIV-associated tuberculosisepidemic in resource-limited settings. Clin ChestMed, 2009, 30(4):685-699, viii.30 Badri M, Wilson D, Wood R. Effect of highly activeantiretroviral therapy on incidence of tuberculosisin South Africa: a cohort study. Lancet, 2002,359(9323):2059-2064.31 Miranda A, Morgan M, Jamal L et al. Impactof antiretroviral therapy on the incidence oftuberculosis: the Brazilian experience, 1995-2001.PLoS One, 2007, 2(9):e826.32 Middelkoop K, Wood, R., Myer, L., Sebastian, E.,Bekker, L.G. Can antiretroviral therapy containa previously escalating TB epidemic in a HIVprevalence community? Can antiretroviral therapycontain a previously escalating TB epidemic in a HIVprevalence community? City, 2009 http://www.ias2009.org/pag/PDF/2932.pdf33 Lawn SD, Myer L, Bekker LG et al. Burden oftuberculosis in an antiretroviral treatmentprogramme in sub-Saharan Africa: impacton treatment outcomes and implications fortuberculosis control. AIDS, 2006, 20(12):1605-1612.34 Lawn SD, Wood R. Incidence of tuberculosis duringhighly active antiretroviral therapy in high-incomeand low-income countries. Clin Infect Dis, 2005,41(12):1783-1786.35 Lawn SD, Myer L, Edwards D et al. Short-term andlong-term risk of tuberculosis associated with CD4cell recovery during antiretroviral therapy in SouthAfrica. AIDS, 2009, 23(13):1717-1725.36 Williams BG, Dye C. Antiretroviral drugs fortuberculosis control in the era of HIV/AIDS. Science,2003, 301(5639):1535-1537.37 Atun RA, Lebcir RM, Drobniewski F et al. Highcoverage with HAART is required to substantiallyreduce the number of deaths from tuberculosis:system dynamics simulation. Int J STD AIDS, 2007,18(4):267-273.38 Golub JE, Durovni B, King BS et al. Recurrenttuberculosis in HIV-infected patients in Rio deJaneiro, Brazil. AIDS, 2008, 22(18):2527-2533.39 Golub JE, Saraceni V, Cavalcante SC et al. Theimpact of antiretroviral therapy and isoniazidpreventive therapy on tuberculosis incidence inHIV-infected patients in Rio de Janeiro, Brazil. AIDS,2007, 21(11):1441-1448.40 Golub JE, Pronyk P, Mohapi L et al. Isoniazidpreventive therapy, HAART and tuberculosis risk inHIV-infected adults in South Africa: a prospectivecohort. AIDS, 2009, 23(5):631-636.41 Abu-Raddad LJ, Sabatelli L, Achterberg JT etal. Epidemiological benefits of more-effectivetuberculosis vaccines, drugs, and diagnostics. ProcNatl Acad Sci U S A, 2009.38